Anthera Pharmaceuticals, Inc. (ANTH)
OTCMKTS: ANTH · Delayed Price · USD
0.0001
0.00 (0.00%)
Aug 29, 2024, 4:00 PM EDT - Market closed
Anthera Pharmaceuticals Statistics
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
ANTH has 26.18 million shares outstanding.
Shares Outstanding | 26.18M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.30
Current Ratio | 3.30 |
Quick Ratio | 3.06 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -568.85% and return on invested capital (ROIC) is -559.32%.
Return on Equity (ROE) | -568.85% |
Return on Assets (ROA) | -141.96% |
Return on Capital (ROIC) | -559.32% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.19M |
Employee Count | 21 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | -127.52 |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 46.94 |
Average Volume (20 Days) | 67 |
Short Selling Information
The latest short interest is 2.02 million, so 7.70% of the outstanding shares have been sold short.
Short Interest | 2.02M |
Short Previous Month | 1.43M |
Short % of Shares Out | 7.70% |
Short % of Float | n/a |
Short Ratio (days to cover) | 2.09 |
Income Statement
Revenue | n/a |
Gross Profit | -28.26M |
Operating Income | -36.80M |
Pretax Income | -23.39M |
Net Income | -24.93M |
EBITDA | -36.40M |
EBIT | -36.80M |
Earnings Per Share (EPS) | -$1.76 |
Balance Sheet
Cash & Cash Equivalents | 8.09M |
Total Debt | n/a |
Net Cash | 8.09M |
Net Cash Per Share | $0.31 |
Equity (Book Value) | 5.46M |
Book Value Per Share | 0.21 |
Working Capital | 6.09M |
Cash Flow
Operating Cash Flow | -31.95M |
Capital Expenditures | n/a |
Free Cash Flow | -31.95M |
FCF Per Share | -$1.22 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ANTH does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -152.23% |
Shareholder Yield | -152.23% |
Earnings Yield | -95,231,721.61% |
FCF Yield | -122,050,618.46% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on May 1, 2017. It was a reverse split with a ratio of 0.125:1.
Last Split Date | May 1, 2017 |
Split Type | Reverse |
Split Ratio | 0.125:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |